Works matching IS 03407004 AND DT 2016 AND VI 65 AND IP 6

Results: 12

Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 727, doi. 10.1007/s00262-016-1836-3

By:

Four, Stephanie;
Maenhout, Sarah;
Benteyn, Daphné;
Keersmaecker, Brenda;
Duerinck, Johnny;
Thielemans, Kris;
Neyns, Bart;
Aerts, Joeri

Publication type:

Article

Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 689, doi. 10.1007/s00262-016-1828-3

By:

Klein, Johanna;
Wild, Clarissa;
Lang, Stephan;
Brandau, Sven

Publication type:

Article

2′-5′ Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 663, doi. 10.1007/s00262-016-1830-9

By:

Sim, Chan;
Cho, Yeon;
Kim, Byung;
Baek, In-Jeoung;
Kim, Young-Joon;
Lee, Myeong

Publication type:

Article

Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 701, doi. 10.1007/s00262-016-1831-8

By:

Cappuccini, Federica;
Stribbling, Stephen;
Pollock, Emily;
Hill, Adrian;
Redchenko, Irina

Publication type:

Article

A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome.

Published in:

2016

By:

Hansen, Elizabeth;
Sahasrabudhe, Deepak;
Sievert, Lynn

Publication type:

Letter

Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 651, doi. 10.1007/s00262-016-1826-5

By:

Noble, Fergus;
Mellows, Toby;
McCormick Matthews, Leo;
Bateman, Adrian;
Harris, Scott;
Underwood, Timothy;
Byrne, James;
Bailey, Ian;
Sharland, Donna;
Kelly, Jamie;
Primrose, John;
Sahota, Surinder;
Bateman, Andrew;
Thomas, Gareth;
Ottensmeier, Christian

Publication type:

Article

Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 715, doi. 10.1007/s00262-016-1837-2

By:

Mizukoshi, Eishiro;
Yamashita, Tatsuya;
Arai, Kuniaki;
Terashima, Takeshi;
Kitahara, Masaaki;
Nakagawa, Hidetoshi;
Iida, Noriho;
Fushimi, Kazumi;
Kaneko, Shuichi

Publication type:

Article

Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 741, doi. 10.1007/s00262-016-1841-6

By:

Chawla, Akhil;
Alatrash, Gheath;
Philips, Anne;
Qiao, Na;
Sukhumalchandra, Pariya;
Kerros, Celine;
Diaconu, Iulia;
Gall, Victor;
Neal, Samantha;
Peters, Haley;
Clise-Dwyer, Karen;
Molldrem, Jeffrey;
Mittendorf, Elizabeth

Publication type:

Article

Strategies to genetically engineer T cells for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 631, doi. 10.1007/s00262-016-1842-5

By:

Spear, Timothy;
Nagato, Kaoru;
Nishimura, Michael

Publication type:

Article

Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 753, doi. 10.1007/s00262-016-1843-4

By:

Kroon, Paula;
Gadiot, Jules;
Peeters, Marlies;
Gasparini, Alessia;
Deken, Marcel;
Yagita, Hideo;
Verheij, Marcel;
Borst, Jannie;
Blank, Christian;
Verbrugge, Inge

Publication type:

Article

Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors 'A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome'.

Published in:

2016

By:

Spain, Lavinia;
Larkin, James;
Martin-Liberal, Juan

Publication type:

Letter

Endostatin inhibits the growth and migration of 4T1 mouse breast cancer cells by skewing macrophage polarity toward the M1 phenotype.

Published in:

Cancer Immunology, Immunotherapy, 2016, v. 65, n. 6, p. 677, doi. 10.1007/s00262-016-1824-7

By:

Guo, Hua;
Liu, Yanan;
Gu, Junlian;
Wang, Yue;
Liu, Lianqin;
Zhang, Ping;
Li, Yang

Publication type:

Article